Market Introduction
The North America transcranial magnetic stimulator (TMS)market has been analyzed on the basis of three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest share in the transcranial magnetic stimulator (TMS) market during the forecast period. The projected growth of the transcranial magnetic stimulator (TMS) market in the US is attributed to the increasing pharmaceutical product manufacturing, rising adoption of advance medical packing technologies by the medical device manufactures is anticipated to fuel growth of the market during the forecast period.
The demand for neuromodulation has increased among the geriatric population, as the exposure to chronic pain is more in the aging population due to comorbidities and potential immune suppression. In addition, the demand is projected to grow among the people suffering from COVID-19 infection and chronic pain, which further results in immunosuppression, complex effects on the immune system. On the other hand, the COVID-19 pandemic has significantly affected the supply chain of medical device industry, due to lockdowns and travel restrictions imposed by governments in different countries and states. The limited production of medical devices was allowed to continue during these periods. However, the current COVID-19 situation in many North American countries is attaining stability in terms of treatment processes, vaccinations, etc. People are opting for their routine treatments and are visiting the clinics and hospitals as per the requirements. The COVID-19 pandemic is expected to slow down the overall North America transcranial magnetic stimulator market growth during the forecast period.
Market Overview and Dynamics
The transcranial magnetic stimulator market in North America is expected to grow from US$ 398.16 million in 2021 to US$ 731.10 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028. The Transcranial Magnetic Stimulator (TMS) is a noninvasive and well-tolerated therapy, and its procedure does not require anesthesia, It is an outpatient service, and patients can continue with daily routines immediately after the treatment. TMS is an innovative and unique type of psychiatric treatment followed by psychiatric mental health professionals. Thus, the acceptance of TMS is rising across the world and resulting in increasing approvals for the products.
Key Market Segments
North America transcranial magnetic stimulator market is segmented into type, age group, application, and country. North America transcranial magnetic stimulator market based on the type was segmented into single or paired pulse TMS, repetitive TMS (rTMS). In 2020, the single or paired pulse TMS segment held the largest share of the market. The North America transcranial magnetic stimulator market, by age group, is segmented into adults and children. The adults segment held the largest share of the market in 2020. The North America transcranial magnetic stimulator market, by application, is segmented into research, diagnostic and therapeutic. The diagnostics segment held the largest share of the market in 2020. Based on country, the North America transcranial magnetic stimulator market is segmented into US, Canada, and Mexico. US held the largest market share in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the transcranial magnetic stimulator market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BrainsWay Ltd; eNeura Inc.; MAG & More GmbH; Magstim; MagVenture, Inc.; Neuronetics; Neurosoft; Nexstim; REMED; and TMS Neuro Solutions.
Reasons to buy report
North America Transcranial Magnetic Stimulator Market Segmentation
North America Transcranial Magnetic Stimulator Market - By Type
North America Transcranial Magnetic Stimulator Market - By Age Group
North America Transcranial Magnetic Stimulator Market - By Application
North America Transcranial Magnetic Stimulator Market - By Country
North America Transcranial Magnetic Stimulator Market - Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 398.16 Million |
| Market Size by 2028 | US$ 731.10 Million |
| CAGR (2021 - 2028) | 9.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Transcranial Magnetic Stimulator Market is valued at US$ 398.16 Million in 2021, it is projected to reach US$ 731.10 Million by 2028.
As per our report North America Transcranial Magnetic Stimulator Market, the market size is valued at US$ 398.16 Million in 2021, projecting it to reach US$ 731.10 Million by 2028. This translates to a CAGR of approximately 9.1% during the forecast period.
The North America Transcranial Magnetic Stimulator Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Transcranial Magnetic Stimulator Market report:
The North America Transcranial Magnetic Stimulator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Transcranial Magnetic Stimulator Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Transcranial Magnetic Stimulator Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Transcranial Magnetic Stimulator Market
